These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 28739288)

  • 1. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.
    Dang XTT; Kavishka JM; Zhang DX; Pirisinu M; Le MTN
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology.
    Martin Perez C; Conceição M; Raz R; Wood MJA; Roberts TC
    Methods Mol Biol; 2022; 2383():119-141. PubMed ID: 34766286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of Biomolecules via Extracellular Vesicles: A Budding Therapeutic Strategy.
    Stranford DM; Leonard JN
    Adv Genet; 2017; 98():155-175. PubMed ID: 28942793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed strategies toward clinical translation of extracellular vesicles.
    Song J; Song B; Yuan L; Yang G
    Theranostics; 2022; 12(15):6740-6761. PubMed ID: 36185609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers.
    Chong SY; Lee CK; Huang C; Ou YH; Charles CJ; Richards AM; Neupane YR; Pavon MV; Zharkova O; Pastorin G; Wang JW
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation.
    Szatmári T; Hargitai R; Sáfrány G; Lumniczky K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.
    Geng T; Pan P; Leung E; Chen Q; Chamley L; Wu Z
    Pharm Res; 2021 Feb; 38(2):179-197. PubMed ID: 33604783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.